Monday 17 September 2018

FDA Approves 2nd Migraine Prevention Drug

stroke illustration

The FDA in May approved a first self-injectable drug, erenumab (Aimovig), made by Amgen and Novartis. It's now offered as once-monthly 70- or 140-milligram prefilled autoinjectors.



from WebMD Health https://ift.tt/2xksqMD

0 comments:

Post a Comment